Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric rheumatology

ACR Hill Visits Yield Key Bill Support; Plus Medicare, Biosimilar Wins

Angus Worthing, MD, FACP, FACR  |  May 20, 2019

Greetings from Washington, D.C., where ACR leaders just held more than 100 meetings on Capitol Hill supporting reforms to step therapy and prior authorization, increased reimbursement for dual-energy X-ray absorptiometry (DXA), solutions to the rheumatology workforce shortage, and rheumatology-specific research at the Pentagon. We’re already hearing great news about our successes: Hours after our visit,…

Filed under:American College of RheumatologyLegislation & AdvocacyMeeting Reports Tagged with:ACR Capitol Hill visitAdvocates for ArthritisBiosimilarsmedical school loansMedicareMedicare Reimbursementpharmacy benefit managers (PBMs)Safe Step Act of 2019 (H.R. 2279)step therapy reform legislation

Olivier Le Moal / shutterstock.com

Dual Certification: Is 1 Head Better Than 2?

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  May 18, 2019

“Hi, I’m Dr. Kumar, and I’m an allergist,” is something I sometimes fumble when I introduce myself to confused rheumatology patients, before I quickly correct myself with, “… well, I’m also a rheumatologist.” There’s a moment of slight embarrassment that I crossed my circuits, but otherwise I’m proud to say I’m certified in both. This…

Filed under:Education & TrainingProfessional Topics Tagged with:Certificationmedical license

Houston Rheumatologist Explores Rarities in Both Medicine & Nature

Linda Childers  |  May 17, 2019

Farokh Jamalyaria, MD, a rheumatologist in Houston, never set out to become a birder. He remembers his first foray into birding as being completely unintentional. At 8 years old, while living in Ruston, La., he showed his mother an image of an ivory-billed woodpecker—an extinct species last spotted in the 1940s about 100 miles from…

Filed under:ProfilesRheum After 5 Tagged with:Dr. Farokh Jamalyaria

ACR/ARP Members Educate Lawmakers

Ryan Basen  |  May 17, 2019

Dozens of rheumatology leaders met with more than 100 politicos on Capitol Hill in mid-May, per the ACR’s annual Advocacy Leadership Conference. Armed with research and advocacy training concerning a handful of important issues, rheumatologists, researchers, government affairs specialists and others met with federal lawmakers, legislative aides and correspondents. The two-day conference, which featured the…

Filed under:Education & TrainingLegislation & AdvocacyMeeting Reports Tagged with:Washington D.C.

Shared Decision Making, Good Disease Control Are Key Components of JIA Management

Kelly Tyrrell  |  May 15, 2019

A group led by Sarah Ringold, MD, MS, assistant professor of rheumatology at Seattle Children’s Hospital, has developed a new guideline intended to provide recommendations for the treatment and monitoring of children with juvenile idiopathic arthritis (JIA) manifesting as non-systemic polyarthritis, sacroiliitis or enthesitis.1,2 Key Updates The new recommendations appear in both Arthritis & Rheumatology…

Filed under:Clinical Criteria/Guidelines Tagged with:Enthesitisjuvenile idiopathic arthritis (JIA)polyarthritissacroiliitisSarah Ringold

New Guideline Recommends Frequent Monitoring & Collaboration for JIA-Associated Uveitis Management

Kelly Tyrrell  |  May 8, 2019

As soon as pediatric patients are diagnosed with juvenile idiopathic arthritis (JIA), they should also be screened for uveitis, says ophthalmologist Gary Holland, MD. Otherwise, the University of California, Los Angeles, provider says, “Kids who are diagnosed with JIA may not come to an ophthalmologist until they have vision-limiting complications.” Uveitis is the most common…

Filed under:Clinical Criteria/GuidelinesConditionsOther Rheumatic Conditions Tagged with:JIA-associated uveitis guidelinejuvenile idiopathic arthritis (JIA)Uveitis

ACR Leaders to Meet with Members of Congress

From the College  |  May 2, 2019

On May 16, ACR and ARP leaders serving on the Board of Directors, Affiliate Society Council, Government Affairs Committee, Committee on Rheumatologic Care, RheumPAC and Insurance Subcommittee will go to Capitol Hill to advocate on behalf of the College’s membership and our patients. The group represents 31 states and the District of Columbia, and will…

Filed under:ConditionsFrom the CollegeLegislation & AdvocacyOsteoarthritis and Bone DisordersWorkforce Tagged with:Capitol Hill fly-inDepartment of Defense (DoD)Ensuring Seniors’ Timely Access to Care Act of 2019Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act (S. 283)OsteoporosisSafe Step Act of 2019 (H.R. 2279)Strengthening our Pediatric Workforce Act (H.R. 1656)

New Tools for Myositis Diagnosis, Classification & Management

Susan Bernstein  |  April 15, 2019

CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:2018 ACR/ARHP Annual Meetingfibrosing myopathyidiopathic inflammatory myopathiesinclusion body myositis (IBM)overlap myositis

Valentyn Volkov / shutterstock.com

Did Shiitake Mushrooms Induce Immune-Mediated Necrotizing Myopathy?

Takeshi Yoshida, MD, Hiroaki Chikazawa, MD, Yoshitaka Kumon, MD, PhD, & Ichizo Nishino, MD, PhD  |  April 15, 2019

Idiopathic inflammatory myopathies are heterogenous, acquired immune-mediated muscle diseases. Over the past decade, immune-mediated necrotizing myopathy has been recognized as a subcategory of idiopathic inflammatory myopathy characterized by myofiber necrosis in the absence of prominent inflammatory cells.1 Autoantibodies against signal recognition particle (SRP) and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) are thought to be associated with the…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:2018 ACR/ARHP Annual Meetingcase reportDietmushroomsnecrotizing myopathyshiitake mushrooms

The ACR Supports Its Members Via Collaboration

Paula Marchetta, MD, MBA  |  April 15, 2019

We all know words can be powerful. They often resonate with several levels of meaning, enriching our understanding and broadening our perspective. Take the word promise, for example. It implies responsibility, as in, “We promise to do it.” It is also imbued with hope, as in “This idea has great promise.” At the ACR we…

Filed under:President's PerspectiveSystemic Lupus Erythematosus Tagged with:Access to careclinical trialsCollaboration InitiativesCollaborative Initiatives Special Committee (COIN)

  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 95
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences